Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 2

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3Thoracic 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 15Squamous Cell Carcinoma of Head and Neck 11Small Cell Lung Carcinoma 9Lung Neoplasms 9Oropharyngeal Neoplasms 7Mouth Neoplasms 6Laryngeal Neoplasms 6Carcinoma 6Uterine Cervical Neoplasms 5Urinary Bladder Neoplasms 5Stomach Neoplasms 4Hypopharyngeal Neoplasms 4Breast Neoplasms 4Adenocarcinoma of Lung 4Pancreatic Neoplasms 3Nasopharyngeal Carcinoma 3Brain Neoplasms 3Vulvar Neoplasms 2Salivary Gland Neoplasms 2Recurrence 2Paranasal Sinus Neoplasms 2Ovarian Neoplasms 2Medulloblastoma 2Lymphoid Interstitial Pneumonia 2Liver Neoplasms 2Head and Neck Neoplasms 2Fallopian Tube Neoplasms 2Cholangiocarcinoma 2Anus Neoplasms 2Urethral Neoplasms 1

Interventions

Temozolomide 73Bevacizumab 57Radiotherapy 40Radiosurgery 28Carboplatin 23Nivolumab 17Etoposide 17Cisplatin 17pembrolizumab 16Irinotecan 16Ipilimumab 15Magnetic Resonance Spectroscopy 14Erlotinib Hydrochloride 14Cyclophosphamide 14Carmustine 14Pemetrexed 13Topotecan 10Surgical Procedures, Operative 10Capecitabine 10Lapatinib 9Filgrastim 9Trastuzumab 8Thalidomide 8Sunitinib 8Paclitaxel 8Lomustine 8Aminolevulinic Acid 8encorafenib 7binimetinib 7Vincristine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Brain Neoplasms × Platinum × Clear all
NCT02595905 2026-04-08

Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases

National Cancer Institute (NCI)

Phase 2 Completed
344 enrolled 11 charts
BreastCNS

Brain Neoplasms, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00031590 2019-04-25

Low-Dose Radiation and Combination Chemotherapy Following Surgery in Children With Newly Diagnosed Medulloblastoma

Children's Hospital of Philadelphia

Phase 2 Terminated
30 enrolled 5 charts
CNS

Brain Neoplasms, Medulloblastoma, Central Nervous System Neoplasms

NCT01578668 2015-01-26

Erlotinib Plus Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases

Guangzhou Medical University

Phase 2 Completed
69 enrolled
CNSThoracic

Adenocarcinoma of Lung, Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡